Storing lyophilised tirzepatide: what the evidence and official guidance actually say

What lyophilised tirzepatide is, and why it matters for storage

Lyophilisation is a freeze-drying process that removes water from a medicine to extend shelf life and improve stability during transport. In pharmaceutical research, tirzepatide has been studied in lyophilised powder form, typically requiring reconstitution with sterile water or a specified diluent before injection. This formulation demands precise handling: the powder must be kept cool and dry, protected from moisture and light, and reconstituted under clean conditions using the exact diluent and volume specified in the study protocol or SmPC.

If you have encountered references to lyophilised tirzepatide (perhaps in a clinical trial document, a research paper, or from an unverified supplier) it is worth pausing. The NHS medicines page for tirzepatide describes the product available in the UK as Mounjaro, a pre-filled KwikPen containing a ready-to-use solution. That is the licensed form. Any powder or vial requiring mixing falls outside the licensed UK supply chain and has not been approved by the MHRA for patient use. Our clinical team takes supply-chain integrity seriously for exactly this reason.

The distinction matters enormously for storage. A ready-to-use biological solution and a lyophilised powder have different stability profiles, different temperature sensitivities, and different failure modes. Using storage instructions designed for one on the other risks degrading the medicine without any visible sign that something has gone wrong.

How the licensed Mounjaro KwikPen should be stored before and after first use

For the pre-filled Mounjaro KwikPen (the product dispensed through the licensed UK supply chain) the SmPC sets out clear requirements. Before first use, pens must be refrigerated at 2°C to 8°C. They should not be frozen: if a pen has been frozen, even briefly, it should not be used. Keep pens away from the freezer compartment or ice packs inside a cool bag during travel.

Once removed from the fridge, there is a limited window during which the pen may be kept at room temperature. The exact duration is stated in the Patient Information Leaflet included with your treatment; how long tirzepatide can be stored at room temperature is something worth reading carefully before you travel or leave a pen on the counter. Never rely on memory or online estimates for this figure, it is product-batch and formulation specific, and the leaflet is the right source.

Light is a further consideration. Pens should remain in their outer carton until you are ready to inject. Direct sunlight and prolonged exposure to bright indoor light can affect biological medicines. A fridge shelf with the carton intact, away from the door (where temperature fluctuates slightly with every opening), is the practical choice most prescribers recommend. Choosing where to keep your pen at home is a small decision with real consequences for the medicine's effectiveness.

Signs that a pen may have been compromised, and what to do

Biological medicines like tirzepatide do not always show visible signs of degradation. A pen that has been left in a hot car, exposed to freezing temperatures, or stored incorrectly for an extended period may look identical to a correctly stored one. That is one reason the MHRA has flagged counterfeit and unverified weight-loss pens as a patient-safety issue, there is no reliable way to assess a pen's integrity by eye alone.

Practical checks you can perform: inspect the solution for cloudiness, discolouration or visible particles before each injection (the solution should be clear or slightly yellow and particle-free). Check the expiry date on the label. If the pen has been outside the fridge for longer than the leaflet permits, do not inject it, contact your prescriber or pharmacist. For guidance on the injection process itself, how to inject tirzepatide covers technique including what to check before each dose.

It can feel frustrating to be told to discard a pen, especially given the cost of private treatment. But the clinical and financial logic is the same: a degraded pen may deliver less medicine than intended, which affects the titration process and your outcomes. If you are on a Mounjaro treatment programme and something seems off with a pen, reaching out to your prescriber is always the right first step. Our team is available seven days a week for exactly these questions.

A note on sourcing and why formulation provenance matters

One reason searches for lyophilised tirzepatide tend to surface is that powder vials and compounded versions of tirzepatide exist in some countries and are sold illegally through unverified online channels. In the UK, tirzepatide is a prescription-only medicine available only as Mounjaro through the licensed supply chain. The MHRA has been clear: purchasing medicines from sellers operating outside that chain, particularly those offering products without a clinical assessment, carries genuine risk of receiving a counterfeit or incorrectly formulated product.

Lyophilised powder in an unlabelled vial offers no assurance of purity, concentration or sterility. Storage instructions passed along with such products are not verified against any regulatory standard. This is not a theoretical concern, the MHRA seized approximately 20 million doses of illegally traded weight-loss medicines worth around £45 million in 2025, and has warned publicly about fake pens containing insulin rather than tirzepatide.

If you are considering starting or continuing tirzepatide treatment, our overview of the Mounjaro injection explains how the licensed product works and what the consultation process involves. For a broader look at weight-loss treatment options, including how tirzepatide fits alongside other licensed medicines, that page is a useful starting point. And if cost is a factor in your thinking, Mounjaro's cost in the UK explains what private pricing typically includes and how to read it.